在90 kVp下肝脏CT成像中按个体体重调整对比剂注射方案
该研究纳入199例门静脉期腹部CT患者,比较固定对比剂方案(100例,总碘量33 g I)与按体重调整方案(99例,0.4 g I/kg)在90 kV下的肝脏强化与图像质量。按体重调整方案使肝实质强化更均匀,各体重组平均强化分别为126.5±15.8、128.2±15.3、122.7±21.2 HU,固定方案分别为139.9±21.4、124.6±24.8、116.2±17.8 HU,客观与主观图像质量相当,且超过半数患者对比剂总量可安全降低。
要点
- 按体重0.4 g I/kg调整对比剂可使肝实质强化更均匀,各体重组强化值分别为126.5±15.8、128.2±15.3、122.7±21.2 HU。
- 固定方案各体重组强化值分别为139.9±21.4、124.6±24.8、116.2±17.8 HU,组间差异明显。
- 两种方案的客观与主观图像质量相当,超过半数患者对比剂总量可安全降低。
核心结论
- 按体重调整对比剂注射方案在90 kV下使肝实质强化更均匀,客观与主观图像质量与固定方案相当,且超过半数患者对比剂总量可安全降低。
研究设计与样本
- 连续纳入199例门静脉期腹部CT患者,组1(n=100)接受固定对比剂剂量33 g I、流率3.5 mL/s、碘输送率1.05 g I/s;组2(n=99)接受按体重0.4 g I/kg调整方案,注射时间均为30秒;按体重分为≤70 kg、71–85 kg、≥86 kg三组。
关键影像表现/征象
- 按体重调整方案各体重组肝实质平均强化分别为126.5±15.8、128.2±15.3、122.7±21.2 HU,较固定方案更均匀。
- 固定方案各体重组肝实质平均强化分别为139.9±21.4、124.6±24.8、116.2±17.8 HU。
- 两组对比剂容积与总碘量差异显著(P<0.01),组1均值110 mL与33 g I,组2均值104.1±21.2 mL与31.2±6.3 g I。
- 两组流率与碘输送率无显著差异(P>0.05)。
诊断标准与关键数值
- 客观图像质量以肝3个段强化值(HU)、信噪比和对比噪声比评估。
- 主观图像质量采用5点Likert量表评估。
- 按体重调整方案剂量因子为0.4 g I/kg,注射时间固定30秒。
- 统计学差异阈值P<0.05。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of the present study was to evaluate the attenuation and image quality (IQ) of a body weight-adapted contrast media (CM) protocol compared with a fixed injection protocol in computed tomography (CT) of the liver at 90 kV.
MATERIALS AND METHODS: One hundred ninety-nine consecutive patients referred for abdominal CT imaging in portal venous phase were included. Group 1 (n = 100) received a fixed CM dose with a total iodine load (TIL) of 33 g I at a flow rate of 3.5 mL/s, resulting in an iodine delivery rate (IDR) of 1.05 g I/s. Group 2 (n = 99) received a body weight-adapted CM protocol with a dosing factor of 0.4 g I/kg with a subsequent TIL adapted to the patients' weight. Injection time of 30 seconds was kept identical for all patients. Therefore, flow rate and IDR changed with different body weight. Patients were divided into 3 weight categories; 70 kg or less, 71 to 85 kg, and 86 kg or greater. Attenuation (HU) in 3 segments of the liver, signal-to-noise ratio, and contrast-to-noise ratio were used to evaluate objective IQ. Subjective IQ was assessed by a 5-point Likert scale. Differences between groups were statistically analyzed (P < 0.05 was considered statistically significant).
RESULTS: No significant differences in baseline characteristics were found between groups. The CM volume and TIL differed significantly between groups (P < 0.01), with mean values in group 1 of 110 mL and 33 g I, and in group 2 of 104.1 ± 21.2 mL and 31.2 ± 6.3 g I, respectively. Flow rate and IDR were not significantly different between groups (P > 0.05). Body weight-adapted protocoling led to more homogeneous enhancement of the liver parenchyma compared with a fixed protocol with a mean enhancement per weight category in group 2 of 126.5 ± 15.8, 128.2 ± 15.3, and 122.7 ± 21.2 HU compared with that in group 1 of 139.9 ± 21.4, 124.6 ± 24.8, and 116.2 ± 17.8 HU, respectively.
CONCLUSIONS: Body weight-adapted CM injection protocols result in more homogeneous enhancement of the liver parenchyma at 90 kV in comparison to a fixed CM volume with comparable objective and subjective IQ, whereas overall CM volume can be safely reduced in more than half of patients.
引用
- Martens B, Hendriks BMF, Eijsvoogel NG, et al. Individually Body Weight-Adapted Contrast Media Application in Computed Tomography Imaging of the Liver at 90 kVp. Invest Radiol. 2019. PMID: 30721159. doi:10.1097/RLI.0000000000000525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。